All Q2 FY27 results →
GF

Gujarat Fluorochemicals Ltd

Q2 FY27Chemicals & Petrochemicals

Gujarat Fluorochemicals Q2 Results 2026 (FY27): Revenue ₹1,760 Cr, PAT ₹240 Cr

Q2 FY27 investor presentation: what the company reported on revenue, margins and capex.

Price₹4,324
Market cap₹47.5K Cr
P/E76.9
Updated3 Nov 2026
Read3 min read

Gujarat Fluorochemicals Ltd Q2 FY27 key numbers

Revenue
Consolidated Q2FY27 revenue: ₹1,760 crore, up 45% YoY (Q2FY26: ₹1,210 crore).

As stated in Gujarat Fluorochemicals Ltd's Q2 FY27 investor presentation · published 3 Nov 2026. Reported figures, not investment advice.

Based on Gujarat Fluorochemicals Ltd's Q2 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

The short version

Consolidated Q2FY27 revenue: ₹1,760 crore, up 45% YoY (Q2FY26: ₹1,210 crore). Q2FY27 EBITDA and Margin: - EBITDA: ₹473 crore (32% YoY growth) - EBITDA Margin: 27% (down 271 bps YoY from 30%) - Operating Revenue: - Consolidated Revenue: ₹1,760 crore (45% YoY growth)

From Gujarat Fluorochemicals Ltd's Q2 FY27 earnings-call transcript · updated 3 Nov 2026.

Revenue & Sales Performance

  • Consolidated Q2FY27 revenue: ₹1,760 crore, up 45% YoY (Q2FY26: ₹1,210 crore).
  • Chemical segment Q2FY27 revenue: ₹1,723 crore, up 42% YoY.
  • Fluoropolymers Q2FY27 revenue: ₹931 crore, up 22% YoY (Q2FY26: ₹764 crore).
  • Fluorochemicals Q2FY27 revenue: ₹607 crore, up 135% YoY (Q2FY26: ₹258 crore).
  • Bulk Chemicals segment revenue declined 5% YoY.
  • Outlook highlights:
  • Fluorochemicals: Stable refrigerant demand and pricing; full R32 capacity utilization expected; R134a production to start by Q4FY27.

2 more points from Gujarat Fluorochemicals Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Gujarat Fluorochemicals Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Total Capex of Rs. 6,000 Cr planned by FY28, targeting 2x Asset Turnover and 25%+ EBITDA margin (Page 24).
  • All initial Phase I capacity commissioned and contracted for anchor clients across all products (Page 24).
  • Setting up NGAAM (Anode Active Material) facility underway (Page 24).
  • Production ramp-up and addition of new plants for LiPF₆ to meet strong demand, backed by multi-year orders (Page 8).
  • Further substantial capacity expansions for LFP grades in progress due to strong global demand (Page 8).
  • PVDF and PTFE grades under advanced customer qualification, with commercial supplies expected from Q4FY27 (Page 8).

2 more points from Gujarat Fluorochemicals Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Shiv Texchem
Rev 1Mar 2
2Yasho Industries
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Gujarat Fluorochemicals Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Gujarat Fluorochemicals Ltd said on order book & pipeline — free account, 30 seconds.

Gujarat Fluorochemicals Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Q2 FY27 figures are not in this chart yet. Latest shown: Mar 2026 (Q4 FY26). The Q2 FY27 numbers from the filing are in the analysis on this page.

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹1.4K Cr, net profit ₹109 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Camlin Fine (Q2 FY27)

    Q2 FY27 revenue: Rs 4,915 mn, up 9.15% YoY from Rs 4,503 mn in Q2 FY26 (Page 6, 9) . Key investor presentation takeaways from Camlin Fine Sciences Ltd's Q2 FY27

  • Bodal Chemicals (Q2 FY27)

    8,840 mn, up 77% YoY (from Rs. Key investor presentation takeaways from Bodal Chemicals Ltd's Q2 FY27 investor presentation — and how it ranks against sector pe

  • Solar Industries (Q2 FY27)

    3,519 crore, up 69% YoY from Rs. Key investor presentation takeaways from Solar Industries India Ltd's Q2 FY27 investor presentation — and how it ranks against

  • Tamil Nadu Petro Products (Q2 FY27)

    For the quarter ended 30-Sep-2026, the standalone revenue from operations was ₹93,437 lakh, up from ₹77,792 lakh in Q2 2025, reflecting a year-on-year…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Gujarat Fluorochemicals Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Gujarat Fluorochemicals Ltd Q2 FY27 results?

Consolidated Q2FY27 revenue: ₹1,760 crore, up 45% YoY (Q2FY26: ₹1,210 crore). Q2FY27 EBITDA and Margin: - EBITDA: ₹473 crore (32% YoY growth) - EBITDA Margin: 27% (down 271 bps YoY from 30%) - Operating Revenue: - Consolidated Revenue: ₹1,760 crore (45% YoY growth)

What is Gujarat Fluorochemicals Ltd share price analysis?

Gujarat Fluorochemicals Ltd currently shows a neutral. The stock trades at a P/E of 76.9 with a market cap of ₹47,500 Cr. Investors should review the full earnings analysis for detailed insights.

Is Gujarat Fluorochemicals Ltd planning capital expenditure?

Total Capex of Rs.

Keep Gujarat Fluorochemicals Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.